Zhongjing Capital
Signal active
Investment Firm
Overview
Zhongjing capital is a private equity investment management institution.
Highlights
Founded
Invalid date
Industry
Employees
0
Investment
9
Lead Investment
0
Exits
undefined
Stages
Private Equity, Early Stage Venture
Investor Type
Private Equity Firm
Location
Asia
Contact Information
Social
Profile Resume
Zhongjing Capital, established in Unknown year and headquartered in Asia., specializes in Private Equity, Early Stage Venture investments across Financial Services, Venture Capital, Telecommunications, Finance, Asset Management, Real Estate, Manufacturing, Medical Device, FinTech, Biotechnology. Their recent investments include Xianghe Capital, Alwin Capital, Gaolin Capital, China Everbright Water, Yichao Medical. The highest investment round they participated in was $1.2B. Among their most notable exits are Xianghe Capital and Alwin Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Zhongjing Capital has made 9 investments. Their most recent investment was on Apr 06, 2024, when Yichao Medical raised $13.8M.
investments
9
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
9
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jan 01, 2022 | Xianghe Capital | Financial Services | null |
| Sep 13, 2022 | Great Bay Bio | Biotechnology | 15.0M |
| Jan 01, 2024 | Verity venture | - | null |
| Apr 06, 2024 | Yichao Medical | Manufacturing | 13.8M |
Exits
0
Funding Timeline
Funding rounds
9
Investors
0
Funds
0
Funding Rounds
9
Zhongjing Capital has raised 9 rounds. Their latest funding was raised on Apr 06, 2024 from a Series B - Yichao Medical round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jan 01, 2022 | Private Equity Round - Xianghe Capital | - | 0 | - |
| Sep 13, 2022 | Series A - Great Bay Bio | - | 15.0M | - |
| Jan 01, 2024 | Private Equity Round - Verity venture | - | 0 | - |
| Apr 06, 2024 | Series B - Yichao Medical | - | 13.8M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.